Sore Throat Clinical Trial
Official title:
A Prospective, Multicenter, Randomized and Single Bind Trial. Influence of Laryngoscope Blade Material on Postoperative PHARYNGEAL AND LARYNGEAL Morbidity Following Scheduled OroTracheal Intubation
Orotracheal intubation following general anesthesia requires blades to be performed. The
risk of patients contamination with infectious agents related to reusable metal blades leads
to promote single-use blades. Some of these latter are plastic and this material may need
more strength to lift the jaw and expose the larynx before orotracheal intubation.
Sometimes, change of blade, from plastic to metal, during the procedure is necessary to
increase the larynx exposure. This change of blade may increase the frequency of sore throat
following orotracheal intubation.
Consequently, the study hypothesis is an increase of both sore throat intensity and
frequency with the plastic blades compared with the metal blades.
The primary purpose of the present study is to compare the impact of these two types of
blades, metal versus plastic, on sore throat intensity and frequency following scheduled
orotracheal intubation for general anesthesia
Trial design :
This will be a multicenter, prospective, randomized and single-blind controlled study
Material and Methods :
The obtaining of the Ethic Committee approval allows the enrolment of 712 patients scheduled
for surgery performed under general anesthesia with orotracheal intubation. Adult patients,
18 to 70 years-old, with grade I-II of ASA (American Society of Anesthesiology) status will
be enrolled after clear information and obtaining, at the anesthesia visit, of the
non-opposition to be enrolled in the trial.
At the anesthesia visit, the anesthesiologist will explain the purpose and protocol to the
patients and then will propose them to participate to the study. The decision to be enrolled
will be known at the pre-anesthesia visit, one day before the surgery. Therefore, the
patients will have a delay between the anesthesia and pre-anesthesia visits to make a
decision. The non-opposition to participate to the trial will be clearly mentioned in the
medical file.
A randomization list will be established by a statistician. Informed and non-opposed
patients will be allocated both a randomization number and a plastic or metal blade in the
operating theatre via the Clean Web software.
The evaluation and measure of the primary outcome will be made in a single-blind way. The
patients will evaluate the sore throat intensity being unaware of the type of blade used for
the orotracheal intubation. An independent research assistant in each centre will collect
data evaluated in both the operating room during the orotracheal intubation procedure and
the post-operative period.
The duration of tracheal intubation will be defined as the time elapsing from the mouth
insertion of the blade to the passage of the tube throughout the vocal cords announced by
the operator. The intra-tracheal position of the tube will be confirmed by three squared
cycles of capnography.
Protocol :
Anesthesia and monitoring:
Patients will be premedicated by hydroxyzine 1 mg kg-1 the previous evening and one hour
before the transfer to the operating room.
The randomization is performed in the operating room just before the anesthesia induction.
The monitoring will be standard with:
- An electrocardiogram (lookout of cardiac rhythm modifications)
- A pulse oxymetry to lookout arterial oxygen saturation
- A non-invasive blood pressure monitoring
- A capnograph to lookout carbon dioxide elimination in the expired gas and to confirm
the intra-tracheal position of the tube
- A gas analyser to control the concentration of administered halogenated volatile agents
- A neuromuscular blockade monitor to lookout the depth of the neuromuscular blockade
required to perform tracheal intubation in optimal conditions. The monitoring will
consist of stimulating the facial nerve 1 cm near the external eyelid corner by a train
of four electric charges (30 mA). The muscular responses will be evaluated on the
corrugator Supercilia by counting the number of contractions.
- A bispectral index (BIS) or entropy to monitor the hypnosis depth. The expected values
will be 40-60 and 25-35, respectively.
- A manometer to control the tracheal tube cuff pressure Before anesthesia induction,
patients will breathe 100% oxygen till expired oxygen concentration reach 90%.
Intravenous anesthesia will be then performed with propofol (1.5-2.5 mg kg -1) as
hypnotic, sufentanil (0.2 mcg kg-1) and atracurium (0.5 mg kg-1) as muscle relaxant.
Cis-atracurium or vecuronium as middle acting muscle relaxant or SUNCCYNILCHOLINE as
short acting muscle relaxant will be authorized. According to the randomization, the
blade used for orotracheal intubation will be metal or plastic. The metal blade is
reusable and the plastic blade is disposable. When the BIS or the entropy will reach
40-60 and 25-35, respectively, with efficient face mask ventilation (good thoracic
amplitude following by capnography cycles), no response to the TOF at the corrugator
Supercilia, the laryngoscopy will be performed according to the orotracheal intubation
algorithm. Tracheal tube sizes will be 7 mm for female and 7.5 for males. Tracheal tube
cuff will be standard.
After tracheal intubation, the anesthesia will be maintained with inhaled halogenated gas or
intravenously. Inhaled gas will be moistened. Postoperative analgesia will be anticipated in
the operating room with paracetamol 1 g, ketoprofen 100 mg and nefopam if necessary. In the
absence of contraindication, the three analgesics will be administered during laparotomies.
Wound and abdominal holes for laparoscopy will be infiltrated with ropivacaine. At the end
of the surgery, the tracheal tube will be withdrawn according to the standard procedure
recommended by the French Anesthesiology Society. Mouth secretions will be suctioned
delicately. In the PACU, analgesia will be continued with according to a protocol adapted to
the type of surgery. Morphine will be administered if pain VAS reaches 4/10. Pharyngeal and
laryngeal morbidity evaluation will begin at the discharge of the PACU and will last 48
hours. If signs persist more than 48 hours, an ENT examination will be performed to make a
diagnostic.
Statistics :
Sample size: The literature reports a 30% incidence of postoperative sore throat with metal
blades. The hypothesis is that this incidence could increase from 30% to 40% if plastic
blades are used. Un sample size of 356 patients per group is required to detect this
increase of 10% with a Chi2 test, a statistic power (1-beta) of 0.80 and alpha type I error
probability of 0.05.
;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject)
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04083417 -
Sore Throat in Primary Care - a Comparison of Phenoxymethylpenicillin and no Antibiotic Treatment
|
Phase 4 | |
Not yet recruiting |
NCT03517215 -
The Development and Testing of a Scaling Strategy for a Community-Based Primary Care Antimicrobial Stewardship Program
|
N/A | |
Not yet recruiting |
NCT01782183 -
Thermographic Characteristics of Sore Throat by Thermographic Camera
|
N/A | |
Completed |
NCT02608788 -
S.L. Spray Solution® and Difflam® and Acular®Spray for the Prevention of Postoperative Sore Throat
|
Phase 4 | |
Completed |
NCT01986361 -
Placebo-Controlled Onset-of-Action Study of Flurbiprofen Utilizing the Double-Stopwatch Method
|
Phase 3 | |
Completed |
NCT03397797 -
Effect of Intraoperative Neuromuscular Blockade on Postoperative Sore Throat and Hoarseness
|
||
Completed |
NCT03282045 -
Efficacy and Safety of the Lysobact Complete Spray®, Tantum Verde® and Pharyngal® Oromucosal Spray in the Treatment of Acute Sore Throat
|
Phase 3 | |
Completed |
NCT01902641 -
Muscle Relaxation for Short Procedures
|
N/A | |
Completed |
NCT01444703 -
Comparison of Licorice Versus Sugar-water Gargle for Prevention of Postoperative Sore Throat and Postextubation Coughing
|
N/A | |
Completed |
NCT00957996 -
Safety Study of IV Peramivir in Hospitalized Subjects With Confirmed or Suspected Influenza
|
Phase 3 | |
Completed |
NCT01033799 -
Effect of the Consumption of a Fermented Milk on Common Infections in Shift-workers
|
N/A | |
Completed |
NCT05069844 -
Preoperative Gum Chewing for Different Durations to Prevent Sore Throat After Endotracheal Intubation
|
N/A | |
Completed |
NCT05247333 -
Implementation of a Minor Ailment Service in Community Pharmacy Practice
|
N/A | |
Recruiting |
NCT03369132 -
Efficacy of Natural Seawater Based Throat Spray in Acute Sore Throat Relief
|
N/A | |
Completed |
NCT02682134 -
Sore Throat Prevention Following Intubation
|
Phase 4 | |
Terminated |
NCT00958776 -
A Study to Evaluate the Efficacy and Safety of IV Peramivir in Addition to Standard of Care Compared to Standard of Care Alone in Adults and Adolescents Who Are Hospitalized Due to Influenza
|
Phase 3 | |
Completed |
NCT00242281 -
APC-111 MP Tablet Once a Day vs.Penicillin VK Four Times a Day Both for 10 Days in Patients With Strep Throat
|
Phase 3 | |
Completed |
NCT03729973 -
Comparing Efficacy Preoperative Nebulized: Ketamine , Mgspo4 ,and Lidocaine In Attenuating Endotracheal Sore Throat
|
Phase 3 | |
Completed |
NCT04085744 -
A Comparison Of Local Anesthetic Agents And Steroid On Tracheal Tube Cuff
|
N/A | |
Completed |
NCT01506583 -
Clinical Evaluation of QFlu Combo Test
|